Product Name | MF | CAS | Details |
---|
(2-Bromo-3-methylphenyl)hydrazine hydrochloride | C7H10BrClN2 | 156941-75-2 | Details |
Cholic Acid-OVA | Details |
Boc-4-methyl-DL-tryptophan | C17H22N2O4 | 1219232-56-0 | Details |
MC 1568 | C17H15FN2O3 | 852475-26-4 | Details |
(S)-N-(Piperidin-3-yl)acetamide hydrochloride | C7H15ClN2O | 1298108-03-8 | Details |
1,4'-Bipiperidine-1-carboxylic chloride hydrochloride | C11H20Cl2N2O | 143254-82-4 | Details |
(2E)-3-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)prop-2-enoic acid | C14H14N2O2 | 27268-08-2 | Details |
4-Amino-N-(4-butylphenyl)-2-methoxybenzene-1-sulfonamide | C17H22N2O3S | 1193389-45-5 | Details |
N-(4-Cyanophenyl)-1,3-thiazolidine-4-carboxamide hydrochloride | C11H12ClN3OS | 1251924-27-2 | Details |
Methyl 2-[(2-methylprop-2-en-1-yl)oxy]benzoate | C12H14O3 | 110124-06-6 | Details |
2-(Aminomethyl)-4,4-dimethylcyclohexan-1-ol | C9H19NO | 1495656-59-1 | Details |
Octyl a-D-thiomannopyranoside | C14H28O5S | 163955-47-3 | Details |
α-Helical CRF (12-41) | C152H251N43O47S2 | 158535-55-8 | Details |
Catalponol methylthiomethyl ether | C17H22O2S | 1432057-74-3 | Details |
Phenyl 3,4-O-isopropylidene-b-D-thiogalactopyranoside | C15H20O5S | 120095-47-8 | Details |
2-Bromo-4-chloro-5-fluoroaniline | C6H4BrClFN | 120694-11-3 | Details |
2-(5-Bromothiophen-2-yl)-2-oxoacetic acid | C6H3BrO3S | 22098-18-6 | Details |
5'-O-Trityl-D3-thymidine | C29H25D3N2O5 | Details |
PSTK Blocking Peptide | Details |
Biotin-a-CGRP (human) | Details |
RKI-1313 | C17H16N4O2S | 1342276-76-9 | Details |
tert-Butyl (tert-butyldimethylsilyl)glyoxylate | C12H24O3Si | 852447-17-7 | Details |
2,4-dimethoxy-6-(morpholin-4-yl)-1,3,5-triazine | C9H14N4O3 | 241483-00-1 | Details |
Indole-2-carboxylic acid tert-butyl ester | C13H15NO2 | 84117-86-2 | Details |
3-Bromo-4-fluoroquinoline | C9H5BrFN | 1824455-38-0 | Details |
ST14 antibody | Details |
2-(3-Bromophenyl)propionaldehyde | C9H9BrO | 59452-90-3 | Details |
phenylcyclopentyl 4-(2-pyridyl)piperazinyl ketone | C21H25N3O | 1024220-23-2 | Details |
2-(4-Bromophenoxy)-2,2-difluoroacetic acid | C8H5BrF2O3 | 1153776-34-1 | Details |
HMGCL protein (His tag) | Details |
4-(Methylsulfonyl)benzyl alcohol | C8H10O3S | 22821-77-8 | Details |
Thymolphthalexon?tetrasodium?salt | C38H45N2NaO12 | 62698-55-9 | Details |
6-Methoxy-2-phenylquinazolin-4(3H)-one | C15H12N2O2 | 1151-70-8 | Details |
H-VHLTPEE-OH | Details |
10-Chloro-3-decyne | C10H17Cl | 18295-64-2 | Details |
Sodium metaborate tetrahydrate | BH8NaO6 | 10555-76-7 | Details |
(4-Chloro-2-cyanophenyl)methanesulfonyl chloride | C8H5Cl2NO2S | 1432681-23-6 | Details |
Melanin production inhibitor A | C16H17NO2 | 346721-60-6 | Details |
4-Ethylbenzophenone | C15H14O | 18220-90-1 | Details |
k-Carrapentaose trisulfate trisodium salt | C30H45O33S3Na3 | Details |
Methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | C10H9NO5S | 35511-14-9 | Details |
3-{[2-(Dimethylamino)ethyl](methyl)amino}propan-1-ol | C8H20N2O | 26439-05-4 | Details |
N-[3-[(Aminoiminomethyl)amino]-4-methylphenyl]-4-[(4-methyl-1-piperazinyl)methyl] benzamide | C21H28N6O | 581076-65-5 | Details |
1-(Chloromethyl)-4-isopropylbenzene | C10H13Cl | 2051-18-5 | Details |
5-Azido-5-deoxy-D-fructose | C6H11N3O5 | 94801-02-2 | Details |
N-(2-Benzoylphenyl)-2-chloroacetamide | C15H12ClNO2 | 23207-75-2 | Details |
UBN1 Blocking Peptide | Details |
Human Serum Albumin (recombinant), Plant | Details |
H-AFDQIDNAPEEK^-OH | Details |
Carbamazepine impurity | C15H14N2O | 3564-73-6 | Details |
3-Bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-A]pyridine | C6H8BrN3 | 1378861-55-2 | Details |
5-Bromomethyl-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester | C7H9BrN2O2 | 878744-22-0 | Details |
δ-3-Carene | C10H16 | 13466-78-9 | Details |
Mouse anti Human IgE (HRP) | Details |
(2R, 3R, 3aS, 9aR) -2, 3, 3a, 9a- Tetrahydro- 3- hydroxy- 6- imino- 3a- methyl- 6H- furo[2', 3':4, 5] oxazolo[3, 2- a] pyrimidine- 2 - methanol | C10H13N3O4 | Details |
3-Chloroisoquinoline | C9H6ClN | 19493-45-9 | Details |
HIV2 RT ROD protein | Details |
Doc-6 (130-145) | Details |
2-Chloro-6-(propan-2-yl)pyrimidin-4-amine | C7H10ClN3 | 1258288-61-7 | Details |
SETDB1 antibody | Details |
CD1d antibody | Details |
2-Ethyl-3-fluorophenol | C8H9FO | 950519-97-8 | Details |
SARS-CoV-2 Spike RBD Antibody Pair 1 | Details |
Chinensine B | C20H28O3 | 849245-34-7 | Details |
(3-fluoro-2-methoxypyridin-4-yl)boronic acid | C6H7BFNO3 | 1598387-84-8 | Details |
N4-Benzoyl-2'-deoxy-5'-O-DMT-5-methylcytidine 3'-CE phosphoramidite | C47H54N5O8P | 105931-57-5 | Details |
8-Methyl-1,2,3,4-tetrahydroquinoline-4-carboxylic acid | C11H13NO2 | 1368799-27-2 | Details |
PNRC1 antibody | Details |
5-Oxo-1,2,3,5-tetrahydroindolizine-3-carboxylic acid | C9H9NO3 | 1369766-08-4 | Details |
4-?Thiomorpholinesulfon?yl chloride 1,?1-?dioxide | C4H8ClNO4S2 | 1154974-57-8 | Details |
N,2-Dimethyl-1,3-benzothiazol-6-amine | C9H10N2S | 42446-08-2 | Details |
1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}azocane-2-carboxylic acid | C23H25NO4 | 1695096-84-4 | Details |
1,2,5,6,7,8-Hexahydroazocin-2-one | C7H11NO | 105495-14-5 | Details |
Beta synuclein antibody | Details |
5-(Chloromethyl)-N,N-dimethylthiophene-2-sulfonamide | C7H10ClNO2S2 | 1486675-03-9 | Details |
Hexacontane | C60H122 | 7667-80-3 | Details |
1-(2,5-Dimethoxyphenyl)-1H-pyrrole-2,5-dione | C12H11NO4 | 40783-24-2 | Details |
Disperse red 88 | 12217-04-8 | Details |
2,3:5,6-Di-O-isopropylidene-L-gulono-1,4-lactone | C12H18O6 | 7306-64-1 | Details |
(6-(Thiophen-3-yl)pyridin-3-yl)methanamine | C10H10N2S | 748121-21-3 | Details |
Guajadial C | C30H34O5 | 1529775-02-7 | Details |
2',3'-Dideoxyuridine-5'-O-monothiophosphate | C9H13N2O6PS | 1266500-91-7 | Details |
Ethyl 3-propylhexanoate | C11H22O2 | 1089315-43-4 | Details |
Propan-2-yl 2-(2-chloroacetamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate | C15H20ClNO3S | 519016-74-1 | Details |
1-{[2-(2,4-Dimethylphenyl)-2-oxoethyl]sulfanyl}-4-[(2-methoxyphenyl)methyl]-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one | C27H24N4O3S | 880279-88-9 | Details |
Methyl 1-fluoro-2-oxocyclooctane-1-carboxylate | C10H15FO3 | 1227407-71-7 | Details |
N-{1,4-Dioxaspiro[4.5]decan-8-ylidene}hydroxylamine | C8H13NO3 | 180918-12-1 | Details |
DRG2 antibody | Details |
5-fluoro-1H-benzo[d][1,3]oxazine-2,4-dione | C8H4FNO3 | 78755-94-9 | Details |
2-Benzyl-3a,6a-dimethyl-octahydropyrrolo[3,4-c]pyrrole dihydrochloride | C15H23ClN2 | 2060005-54-9 | Details |
Recombinant Human MIP-1beta | Details |
6-(Ferrocenyl)hexanethiol | C11H17S.C5H5.Fe | 134029-92-8 | Details |
Aldol??455 beta-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 | C27H24ClNO7 | 1318785-27-1 | Details |
Lithium 5-bromo-1,3,4-thiadiazole-2-carboxylate | C3H2BrLiN2O2S | 2248327-17-3 | Details |
tert-Butyl N-(3,3,3-trifluoropropyl)carbamate | C8H14F3NO2 | 1384428-84-5 | Details |
(D-Leu6)-LHRH (1-8) (free acid) trifluoroacetate salt | C52H72N14O12 | 112642-14-5 | Details |
1-(5-Chloro-2-methoxyphenyl)-3,3,3-trifluoropropan-1-one | C10H8ClF3O2 | 1334149-20-0 | Details |
6-Bromo-4-oxo-1,4-dihydroquinoline-3-carbonitrile | C10H5BrN2O | 364793-52-2 | Details |
DUT Blocking Peptide | Details |
H-SGEGWPYIACRTSVVGRAWE-OH | Details |
Product Total: Product Page: | ||||
915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 |